Information about CSRD
My details
*
*
*

CSRD (SRL)

BE

0805.558.967

Company information

Status
Active

Enterprise number

BE0805.558.967

VAT liability
Yes
Established
07-09-2023
Last balance sheet year
2025
Company size
Micro 0 FTE
Legal form
Société à responsabilité limitée (SRL)
Commercial name
ConverSant
Full name
ConverSant R&D
Principal activity
Other business support service activities n.e.c.
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from CSRD

2025 2024 2023
Income statement
Profit/Loss € 6,622 -93% € 93,099 758% € 10,853
Gross margin € 16,533 -87% € 126,677 731% € 15,248
Balance sheet
Balance sheet total € 131,724 -12% € 149,633 467% € 26,378
Equity € 115,574 6% € 108,952 587% € 15,853
Debts € 16,150 -60% € 40,681 287% € 10,525

Publications from CSRD

Date Publication
11-09-2023 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the VAT number of ConverSant R&D?
The VAT number of ConverSant R&D is BE 0805.558.967.
Wat is the PEPPOL ID of ConverSant R&D?
The PEPPOL ID of ConverSant R&D is 0208:0805558967. Log in or start a free trial to see the full overview.
When was ConverSant R&D founded?
ConverSant R&D was founded on 07-09-2023.
What is the address of ConverSant R&D?
The current registered office of ConverSant R&D is located at Elenestraat 153, 9620 Zottegem.
When was the last time ConverSant R&D filed their annual financial statements?
The most recent financial statements of ConverSant R&D were filed on 30-07-2026.
How many employees does ConverSant R&D have?
There are currently no employees working at ConverSant R&D or no workforce information is available.
What is the annual turnover of ConverSant R&D?
At the time of its most recent financial statements, ConverSant R&D did not publish any turnover figures. ConverSant R&D reported a gross margin of €16,532.75.

Sources